Hls Therapeutics (TSE:HLS) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
HLS Therapeutics Inc. is set to release its first-quarter financial results for fiscal year 2024 on May 9, with a conference call scheduled for that morning. Investors and interested parties can join the call via webcast or traditional phone lines, with a taped replay available for two weeks following the event. HLS specializes in acquiring and commercializing pharmaceuticals for psychiatric and cardiovascular diseases in North American markets.
For further insights into TSE:HLS stock, check out TipRanks’ Stock Analysis page.